Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Carballo

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Atherosclerosis|October 1, 2021
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patientsThabo Mahendiran, Roland Klingenberg, David Nanchen, et al.
International Journal of Cardiology. Heart & Vasculature|April 22, 2026
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarctionTim Horbach, Florian A Wenzl, Robert Manka, et al.
Environmental Health Perspectives|April 28, 2012
Heart rate variability in association with frequent use of household sprays and scented products in SAPALDIAAmar J Mehta, Martin Adam, Emmanuel Schaffner, et al.
International Journal of Cardiology|November 1, 2019
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitorsAudrey Butty, Baris Gencer, Konstantinos C Koskinas, et al.
Journal of Interventional Cardiology|March 25, 2020
Optimal Timing of Invasive Coronary Angiography following NSTEMIThabo Mahendiran, David Nanchen, David Meier, et al.
European Journal of Internal Medicine|January 14, 2015
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Journal of Cardiovascular Translational Research|November 27, 2019
Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary SyndromesThabo Mahendiran, David Nanchen, Baris Gencer, et al.
Swiss Medical Weekly|October 31, 2014
Early detection of subjects at risk for vascular remodelling - results from the Swiss population-based study SAPALDIAJulia Dratva, Seraina Caviezel, Emmanuel Schaffner, et al.
International Journal of Cardiology|December 21, 2019
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortBaris Gencer, David Carballo, David Nanchen, et al.
Circulation|July 28, 2016
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesDavid Nanchen, Baris Gencer, Olivier Muller, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Atherosclerosis|October 1, 2021
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patientsThabo Mahendiran, Roland Klingenberg, David Nanchen, et al.
International Journal of Cardiology. Heart & Vasculature|April 22, 2026
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarctionTim Horbach, Florian A Wenzl, Robert Manka, et al.
Environmental Health Perspectives|April 28, 2012
Heart rate variability in association with frequent use of household sprays and scented products in SAPALDIAAmar J Mehta, Martin Adam, Emmanuel Schaffner, et al.
International Journal of Cardiology|November 1, 2019
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitorsAudrey Butty, Baris Gencer, Konstantinos C Koskinas, et al.
Journal of Interventional Cardiology|March 25, 2020
Optimal Timing of Invasive Coronary Angiography following NSTEMIThabo Mahendiran, David Nanchen, David Meier, et al.
European Journal of Internal Medicine|January 14, 2015
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Journal of Cardiovascular Translational Research|November 27, 2019
Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary SyndromesThabo Mahendiran, David Nanchen, Baris Gencer, et al.
Swiss Medical Weekly|October 31, 2014
Early detection of subjects at risk for vascular remodelling - results from the Swiss population-based study SAPALDIAJulia Dratva, Seraina Caviezel, Emmanuel Schaffner, et al.
International Journal of Cardiology|December 21, 2019
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortBaris Gencer, David Carballo, David Nanchen, et al.
Circulation|July 28, 2016
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesDavid Nanchen, Baris Gencer, Olivier Muller, et al.
Pageof 10